Poseida Therapeutics to Present anti-PSMA CAR-T Preclinical Data at the Society for Immunotherapy of Cancer (SITC … – Markets Insider
Poseida Therapeutics to Present anti-PSMA CAR-T Preclinical Data at the Society for Immunotherapy of Cancer (SITC …Markets Insider“P‐PSMA‐101 is a CAR-T cell therapeutic that exhibits a persistently high percentage of stem cell memory T-cells and med… Continue reading
